NIH cuts impacted 74,000 clinical trial patients: study
Summary
President Trump's administration ended federal research grants funded by the National Institutes of Health (NIH), affecting around 1 in 30 clinical trials. This change impacted over 74,000 patients involved in these trials. The cuts affected primarily diverse topics, with a focus on infectious diseases, and raised concerns about commitments to patients and research quality.Key Facts
- The Trump administration cut NIH research grants, disrupting 1 in 30 ongoing clinical trials.
- Over 74,000 patients were affected by these interruptions.
- NIH funding cuts totaled $3.8 billion and targeted diversity, equity, and inclusion projects.
- Between February 28 and August 15, 383 out of 11,008 funded trials had their grants terminated.
- 14% of trials focusing on infectious diseases lost their funding, the highest among trial types.
- 6% of respiratory illness and 5% of cardiovascular trials also lost funding.
- Concerns were raised about broken commitments to patients and potential impacts on research quality.
- HHS stated the study misrepresented their grant management process, emphasizing a focus on high-impact research.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.